October 08, 2020
Legacy Pharmaceutical Packaging is recalling 111,948 bottles of 1000-mg metformin hydrochloride tablets. According to the October 7, 2020, US Food and Drug Administration (FDA) Enforcement Report, metformin tablets with a different imprint but the same strength were found in the bottles.
Recalled are 60-count bottles of metformin hydrochloride tablets, 1000 mg (NDC 68645-545-59), from lot 201626 (Exp. 8/22). The bottles were manufactured for Heritage Pharmaceuticals Inc., packaged by Legacy Pharmaceutical Packaging, and distributed by Walmart distribution centers in Georgia and Arkansas.
Legacy Pharmaceutical Packaging voluntarily initiated the recall September 24, 2020. The FDA designated the recall Class III on September 30, 2020. Under the recall classification, use of the affected tablets is not likely to cause harm.
Metformin is a prescription drug used to help control blood sugar levels in adults with type 2 diabetes.